Healthy volunteers help Fine-Tune new drug formulation
NCT ID NCT06670950
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study in 28 healthy adults aims to compare how well a new formulation of the drug SYT-510 is absorbed, and whether food changes its effects. Part 1 looks at single doses under different conditions, while Part 2 tests multiple doses to check safety and how the drug moves through the body. The results will guide future dosing decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- SYT-510
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Richmond Pharmacology Ltd
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a new oral drug change future treatments? early safety trial begins
- Can brain scans unlock the secret to hearing in crowded rooms?
- Can a Light-Guided device make arterial sticks easier?
- Water workouts could be the key to back pain relief
- Could everyday disinfectants be harming us? a new study investigates
- Can a new drug keep the Heart's beat steady? trial puts verducatib to the test